Vir Biotechnology, Inc. Contracts & Agreements

106 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amended and Restated Collaboration and License Agreement between Vir Biotechnology, Inc. and Alnylam Pharmaceuticals, Inc.
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
NY
2025
Promotion Letter and Equity Award Agreement for Vanina de Verneuil – Vir Biotechnology, Inc.
Compensation Agreements
Vir Biotechnology, Inc.
Biotechnology
2025
Vir Biotechnology, Inc. Change in Control and Severance Benefit Plan (Amended and Restated as of January 1, 2025)
Change of Control Agreements
Vir Biotechnology, Inc.
Biotechnology
CA
2025
License Agreement between Amunix Pharmaceuticals, Inc. and Vir Biotechnology, Inc. (July 31, 2024)
License Agreements
Vir Biotechnology, Inc.
Biotechnology
DE
2024
Amendment No. P00002 to Other Transaction Agreement No. 75A50122C00081 between Vir Biotechnology, Inc. and the U.S. Department of Health and Human Services (BARDA)
Development Agreements
Vir Biotechnology, Inc.
Biotechnology
2024
Amendment No. P00003 to Other Transaction Agreement No. 75A50122C00081 between Vir Biotechnology, Inc. and HHS/BARDA
Modification Agreements
Vir Biotechnology, Inc.
Biotechnology
2024
Letter Agreement for Termination of Influenza Program under Collaboration Agreement between Glaxo Wellcome UK Limited and Vir Biotechnology, Inc.
Termination Agreements
Vir Biotechnology, Inc.
Biotechnology
2024
Separation Agreement between Vir Biotechnology International GmbH and Johanna Friedl-Naderer
Separation Agreements
Vir Biotechnology, Inc.
Biotechnology
DE
2023
Other Transaction for Advanced Research Agreement between Vir Biotechnology, Inc. and the U.S. Department of Health and Human Services (BARDA)
Development Agreements
Vir Biotechnology, Inc.
Biotechnology
2023
Amendment No. P00001 to OTAR Agreement No. 75A50122C00081 Between Vir Biotechnology, Inc. and HHS/BARDA
Funding Agreements
Vir Biotechnology, Inc.
Biotechnology
2023
Termination Agreement between Vir Biotechnology, Inc. and WuXi Biologics (Hong Kong) Limited (May 16, 2022)
Termination Agreements
Vir Biotechnology, Inc.
Biotechnology
CA
2022
Amendment No. 1 to Definitive Collaboration Agreement by and among Glaxo Wellcome UK Limited, GlaxoSmithKline Biologicals S.A., and Vir Biotechnology, Inc.
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
DE
2022
Amendment to Grant Agreement Between Bill & Melinda Gates Foundation and Vir Biotechnology Inc. (No Cost Extension)
Modification Agreements
Vir Biotechnology, Inc.
Biotechnology
2022
Amended and Restated Strategic Relationship Letter Agreement between Bill & Melinda Gates Foundation and Vir Biotechnology, Inc.
Investment Agreements
Vir Biotechnology, Inc.
Biotechnology
WA
2022
Stock Purchase Agreement between Bill & Melinda Gates Foundation and Vir Biotechnology, Inc. (January 12, 2022)
Stock Agreements
Vir Biotechnology, Inc.
Biotechnology
DE
2022
Preliminary Collaboration Agreement between Glaxo Wellcome UK Limited and Vir Biotechnology, Inc.
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
2021
Stock Purchase Agreement between Vir Biotechnology, Inc. and Glaxo Group Limited (GSK) dated February 14, 2021
Stock Agreements
Vir Biotechnology, Inc.
Biotechnology
DE
2021
Amendment No. 1 to Patent License Agreement between Vir Biotechnology, Inc. and Xencor, Inc.
License Agreements
Vir Biotechnology, Inc.
Biotechnology
NY
2021
Amendment No. 1 to Patent License Agreement between Vir Biotechnology, Inc. and Xencor, Inc.
License Agreements
Vir Biotechnology, Inc.
Biotechnology
NY
2021
Amendment No. 3 to Exclusive License Agreement between The Rockefeller University and Vir Biotechnology, Inc.
License Agreements
Vir Biotechnology, Inc.
Biotechnology
2021
Vir Biotechnology, Inc. 2019 Equity Incentive Plan Restricted Stock Unit Grant Notice and Award Agreement
Equity Distribution Agreements
Vir Biotechnology, Inc.
Biotechnology
2021
Vir Biotechnology, Inc. Non-Employee Director Compensation Policy
Compensation Agreements
Vir Biotechnology, Inc.
Biotechnology
2021
Letter Amendment to Collaboration and License Agreement between Alnylam Pharmaceuticals, Inc. and Vir Biotechnology, Inc. (December 23, 2020)
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
2021
Amendment Number One to License Agreement between MedImmune, LLC and Vir Biotechnology, Inc.
License Agreements
Vir Biotechnology, Inc.
Biotechnology
2021
Amendment to Grant Agreement Between Bill & Melinda Gates Foundation and Vir Biotechnology Inc.
Modification Agreements
Vir Biotechnology, Inc.
Biotechnology
2021
Amendment to Grant Agreement Between Bill & Melinda Gates Foundation and Vir Biotechnology, Inc.
Modification Agreements
Vir Biotechnology, Inc.
Biotechnology
2021
Second Amendment to Exclusive License Agreement between The Rockefeller University and Vir Biotechnology, Inc.
License Agreements
Vir Biotechnology, Inc.
Biotechnology
2021
Amendment to Grant Agreement Between Bill & Melinda Gates Foundation and Vir Biotechnology Inc. (May 29, 2020)
Modification Agreements
Vir Biotechnology, Inc.
Biotechnology
2020
Vir Biotechnology, Inc. Common Stock Underwriting Agreement with Goldman Sachs & Co. LLC, July 2020
Underwriting Agreements
Vir Biotechnology, Inc.
Biotechnology
NY
2020
Amendment No. 3 to Collaboration and License Agreement between Vir Biotechnology, Inc. and Alnylam Pharmaceuticals, Inc.
License Agreements
Vir Biotechnology, Inc.
Biotechnology
2020
Preliminary Collaboration Agreement between GlaxoSmithKline and Vir Biotechnology, Inc. (April 5, 2020)
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
DE
2020
Definitive Collaboration Agreement among Glaxo Wellcome UK Limited, Beecham S.A., and Vir Biotechnology, Inc.
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
DE
2020
Stock Purchase Agreement between Glaxo Group Limited and Vir Biotechnology, Inc. dated April 5, 2020
Stock Agreements
Vir Biotechnology, Inc.
Biotechnology
DE
2020
Clinical Development and Manufacturing Agreement between Biogen Inc. and Vir Biotechnology, Inc. (May 22, 2020)
Development Agreements
Vir Biotechnology, Inc.
Biotechnology
DE
2020
Binding Letter Agreement for Manufacturing Services and Capacity Reservation between Vir Biotechnology, Inc. and Samsung BioLogics Co., Ltd.
Development Agreements
Vir Biotechnology, Inc.
Biotechnology
2020
Development and Manufacturing Collaboration Agreement between Vir Biotechnology, Inc. and WuXi Biologics (Hong Kong) Limited
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
IL
2020
Letter of Intent for Manufacturing Services between Vir Biotechnology, Inc. and WuXi Biologics (Hong Kong) Limited
Development Agreements
Vir Biotechnology, Inc.
Biotechnology
2020
Description of Capital Stock and Anti-Takeover Provisions of Vir Biotechnology, Inc.
Stock Agreements
Vir Biotechnology, Inc.
Biotechnology
2020
Amendment to Amended Offer Letter between Vir Biotechnology, Inc. and Michael Kamarck, PhD (March 13, 2020)
Employment Agreements
Vir Biotechnology, Inc.
Biotechnology
2020
Amendment No. 1 to Collaboration and License Agreement between Vir Biotechnology, Inc. and Alnylam Pharmaceuticals, Inc.
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
2020
Amendment No. 2 to Collaboration and License Agreement between Vir Biotechnology, Inc. and Alnylam Pharmaceuticals, Inc.
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
2020
Amendment No. 1 to Common Stock Issuance Agreement between Vir Biotechnology, Inc. and Alnylam Pharmaceuticals, Inc.
Stock Agreements
Vir Biotechnology, Inc.
Biotechnology
2020
Amendment No. 1 to Grant Agreement between Bill & Melinda Gates Foundation and Vir Biotechnology, Inc.
Funding Agreements
Vir Biotechnology, Inc.
Biotechnology
2020
Amendment No. 2 to Grant Agreement between Bill & Melinda Gates Foundation and Vir Biotechnology Inc.
Funding Agreements
Vir Biotechnology, Inc.
Biotechnology
2020
Amendment to Grant Agreement Between Bill & Melinda Gates Foundation and Vir Biotechnology, Inc.
Modification Agreements
Vir Biotechnology, Inc.
Biotechnology
2020
Amendment to Grant Agreement Between Bill & Melinda Gates Foundation and Vir Biotechnology, Inc.
Modification Agreements
Vir Biotechnology, Inc.
Biotechnology
2020
Vir Biotechnology, Inc. Common Stock Underwriting Agreement with Goldman Sachs, J.P. Morgan, Cowen, and Barclays (2019)
Underwriting Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
Vir Biotechnology, Inc. Common Stock Certificate Issued to Shareholder
Stock Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
Vir Biotechnology, Inc. 2019 Equity Incentive Plan
Equity Distribution Agreements
Vir Biotechnology, Inc.
Biotechnology
DE
2019
Vir Biotechnology, Inc. 2019 Employee Stock Purchase Plan
Equity Distribution Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
Vir Biotechnology, Inc. Non-Employee Director Compensation Policy
Compensation Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
Amended and Restated Investors' Rights Agreement between Vir Biotechnology, Inc. and Investors (November 29, 2017)
Investor Rights Agreements
Vir Biotechnology, Inc.
Biotechnology
DE
2019
Amended and Restated Warrant to Purchase Series A-1 Preferred Stock between Vir Biotechnology, Inc. and Takeda Ventures, Inc.
Warrant Agreements
Vir Biotechnology, Inc.
Biotechnology
DE
2019
Indemnity Agreement between Vir Biotechnology, Inc. and Indemnitee
Indemnification Agreements
Vir Biotechnology, Inc.
Biotechnology
DE
2019
Vir Biotechnology, Inc. 2019 Equity Incentive Plan
Equity Distribution Agreements
Vir Biotechnology, Inc.
Biotechnology
DE
2019
Vir Biotechnology, Inc. 2019 Equity Incentive Plan Stock Option Grant Notice and Agreement
Warrant Agreements
Vir Biotechnology, Inc.
Biotechnology
IL
2019
Vir Biotechnology, Inc. 2019 Equity Incentive Plan Restricted Stock Unit Grant Notice and Award Agreement
Equity Distribution Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
Vir Biotechnology, Inc. 2016 Equity Incentive Plan (Amended and Restated as of August 26, 2019)
Equity Distribution Agreements
Vir Biotechnology, Inc.
Biotechnology
DE
2019
Vir Biotechnology, Inc. 2016 Equity Incentive Plan Incentive Stock Option Grant Agreement
Equity Distribution Agreements
Vir Biotechnology, Inc.
Biotechnology
DE
2019
Vir Biotechnology, Inc. 2019 Employee Stock Purchase Plan
Stock Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
Vir Biotechnology, Inc. Employment Agreement with Michael Kamarck, PhD (Chief Technology Officer)
Employment Agreements
Vir Biotechnology, Inc.
Biotechnology
CA
2019
Vir Biotechnology, Inc. Chief Medical Officer Employment Agreement with Phil Pang, MD, PhD (August 27, 2019)
Employment Agreements
Vir Biotechnology, Inc.
Biotechnology
CA
2019
Vir Biotechnology, Inc. Chief Business Officer Employment Agreement with Jay Parrish, PhD (August 27, 2019)
Employment Agreements
Vir Biotechnology, Inc.
Biotechnology
CA
2019
Vir Biotechnology, Inc. Change in Control and Severance Benefit Plan (March 2019)
Change of Control Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
Collaboration and License Agreement between Vir Biotechnology, Inc. and Alnylam Pharmaceuticals, Inc. (October 16, 2017)
License Agreements
Vir Biotechnology, Inc.
Biotechnology
MA
2019
Common Stock Issuance Agreement between Vir Biotechnology, Inc. and Alnylam Pharmaceuticals, Inc.
Stock Agreements
Vir Biotechnology, Inc.
Biotechnology
CA
2019
Letter Agreement Regarding Program Transaction Revenue Sharing Between Alnylam Pharmaceuticals, Inc. and Vir Biotechnology, Inc.
Financing Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
License Agreement between MedImmune, LLC and Vir Biotechnology, Inc. (September 7, 2018)
License Agreements
Vir Biotechnology, Inc.
Biotechnology
IL
2019
Second Revised and Restated Master Exclusive License Agreement between OHSU and Vir Biotechnology, Inc.
License Agreements
Vir Biotechnology, Inc.
Biotechnology
OR
2019
Side Letter Agreement Regarding Win State Payments between Vir Biotechnology, Inc. and TomegaVax, Inc. Stockholders
Merger Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
Agreement and Plan of Merger among Vir Biotechnology, Inc., Vir Merger Sub, Inc., Agenovir Corporation, and Equityholders Representative (Dr. Stephen R. Quake)
Merger Agreements
Vir Biotechnology, Inc.
Biotechnology
DE
2019
Securities Purchase Agreement among Vir Biotechnology, Inc., Humabs BioMed SA, Securityholders, and Fortis Advisors LLC (August 22, 2017)
Purchase Agreements
Vir Biotechnology, Inc.
Biotechnology
NY
2019
Strategic Relationship Letter Agreement between Bill & Melinda Gates Foundation and Vir Biotechnology, Inc. (December 23, 2016)
Investment Agreements
Vir Biotechnology, Inc.
Biotechnology
WA
2019
Grant Agreement Between Bill & Melinda Gates Foundation and Vir Biotechnology, Inc. for HIV Vaccine Development
Funding Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
Grant Agreement Between Bill & Melinda Gates Foundation and Vir Biotechnology, Inc. for CMV-TB Vaccine Development
Funding Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
Amended and Restated Exclusive License Agreement between Institute for Research in Biomedicine and Humabs Holding GmbH
License Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
Amendment to License Agreement between Humabs Holding GmbH and Institute for Research in Biomedicine (February 10, 2012)
License Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
Exclusive License Agreement between Institute for Research in Biomedicine and Humabs Biomed SA
License Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
Amendment to License Agreement between Humabs Biomed SA and Institute for Research in Biomedicine (February 10, 2012)
License Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
Amendment Agreement to License Agreements between Institute for Research in Biomedicine and Humabs BioMed SA (January 29, 2018)
Modification Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
Exclusive License Agreement between Vir Biotechnology, Inc. and The Rockefeller University
License Agreements
Vir Biotechnology, Inc.
Biotechnology
NY
2019
Amendment to Exclusive License Agreement between The Rockefeller University and Vir Biotechnology, Inc.
License Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
Sub-Licence and Collaboration Agreement between MedImmune, LLC and Humabs BioMed SA (March 20, 2012)
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
NY
2019
Extension Notice and Research Funding Adjustment under Sub-License and Collaboration Agreement between MedImmune LLC and Humabs BioMed SA
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
Amendment No. 2 to Sub-License and Collaboration Agreement between MedImmune, LLC and Humabs BioMed SA
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
Amendment No. 3 to Sub-Licence and Collaboration Agreement between MedImmune, LLC and Humabs BioMed SA
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
Fourth Amendment to Sub-Licence and Collaboration Agreement between MedImmune, LLC and Humabs BioMed SA
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
Amendment 5 to Sub-License and Collaboration Agreement between MedImmune, LLC and Humabs BioMed SA
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
Amendment No. 6 to Sub-Licence and Collaboration Agreement between Humabs Biomed SA and MedImmune, LLC
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
Patent License Agreement between Vir Biotechnology, Inc. and Xencor, Inc. (August 15, 2019)
License Agreements
Vir Biotechnology, Inc.
Biotechnology
NY
2019
Collaboration, Option, and License Agreement between Vir Biotechnology, Inc., Brii Biosciences Limited, and Brii Biosciences Offshore Limited
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
NY
2019
Vir Biotechnology, Inc. Non-Employee Director Compensation Policy
Compensation Agreements
Vir Biotechnology, Inc.
Biotechnology
2025
Vir Biotechnology, Inc. Discretionary Bonus Plan Agreement
Bonus & Incentive Agreements
Vir Biotechnology, Inc.
Biotechnology
DE
2025
Vir Biotechnology, Inc. Offer Letter to Mark Eisner for Executive Vice President, Chief Medical Officer
Employment Agreements
Vir Biotechnology, Inc.
Biotechnology
CA
2025
Vir Biotechnology, Inc. Executive Employment Offer Letter to Jason for EVP, CFO Position
Employment Agreements
Vir Biotechnology, Inc.
Biotechnology
CA
2024
Grant Agreement Between Vir Biotechnology Inc. and Bill & Melinda Gates Foundation for TB and HIV Vaccine Development
Vir Biotechnology, Inc.
Biotechnology
2022
Grant Agreement Between Vir Biotechnology Inc. and Bill & Melinda Gates Foundation for HIV and Malaria Antibody Development
Vir Biotechnology, Inc.
Biotechnology
2022
Vir Biotechnology, Inc. Chief Technology Officer Employment Agreement with Ann (Aine) M. Hanly (May 2021)
Employment Agreements
Vir Biotechnology, Inc.
Biotechnology
CA
2021
Vir Biotechnology, Inc. Employment Agreement with Steven Rice (Head of Human Resources)
Employment Agreements
Vir Biotechnology, Inc.
Biotechnology
CA
2020
Promotion and Stock Option Grant Letter to Steven – Chief Administrative Officer Appointment (Vir Biotechnology, Inc.)
Employment Agreements
Vir Biotechnology, Inc.
Biotechnology
2020
Vir Biotechnology, Inc. Non-Employee Director Compensation Policy
Compensation Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
Vir Biotechnology, Inc. CEO Employment Agreement with George Scangos, PhD (August 27, 2019)
Employment Agreements
Vir Biotechnology, Inc.
Biotechnology
CA
2019
Vir Biotechnology, Inc. Chief Financial Officer Employment Agreement with Howard Horn (August 27, 2019)
Employment Agreements
Vir Biotechnology, Inc.
Biotechnology
CA
2019
Vir Biotechnology, Inc. Executive Employment Agreement with Herbert "Skip" Virgin IV, MD, PhD (September 3, 2019)
Employment Agreements
Vir Biotechnology, Inc.
Biotechnology
CA
2019
Lease Agreement between ARE-San Francisco No. 43, LLC and Vir Biotechnology, Inc. for 499 Illinois Street, San Francisco
Lease Agreements
Vir Biotechnology, Inc.
Biotechnology
IL
2019
First Amendment to Lease Agreement between ARE-San Francisco No. 43, LLC and Vir Biotechnology, Inc.
Lease Agreements
Vir Biotechnology, Inc.
Biotechnology
2019